2006, Número 6
<< Anterior Siguiente >>
Med Cutan Iber Lat Am 2006; 34 (6)
Incidencia de androgenetica alopecia en mujeres de síndrome de ovarios policísticos
Carvalho LJA, Padovez F
Idioma: Portugués
Referencias bibliográficas: 12
Paginas: 275-278
Archivo PDF: 162.47 Kb.
FRAGMENTO
No tiene resumen
REFERENCIAS (EN ESTE ARTÍCULO)
Lobo R, Carmina E, The Importance of Diagnosing the Polycystic Ovary Syndrome. Ann Intern Med 2000;132:989-993.
Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in Adolescent Girls with Polycystic Ovary Syndrome. Arch Pediatr Adolesc Med 2002;156:556-560.
Tartagni M, Schonauer LM, De Salvia MA, et al. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2000;73:718-723.
Kovacs GT. Polycystic Ovary Syndrome. Cambridge University Press, 2000,UK.
Ludwig E. Classification of the types of androgenetic alopecia occuring in the female sex. Br J Dermatol 1977;97:247-254.
6.Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005; 52:301-311.
Shaw JC. Hormonal therapy in Dermatology. Dermatol Clin 2001;19:169-178.
8.Meisler JG. Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women. J Women Health 2003;12:533-539.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
Frishberg DP, Sperling LC, Guthrie VM. Transversal scalp sections: a proposed method for laboratory processing. J Am Acad Dermatol 1996;35(2pt1):220-222.
Pereira, JM. Propedêutica das doenças dos cabelos e do couro cabeludo. 1ª. Edição, São Paulo: Editora Atheneu, 2001, pp.113-116.
Lobo R, Carmina E. The Importance of Diagnosing the Polycystic Ovary Syndrome. Ann Intern Med 2000;132:989-993.
Texto completo
Cómo citar este artículo